Abstract:Introduction: Preoperative risk stratification of kidney cancer patients is critical for treatment selection and improving mortality rates. Current clinical approaches such as cancer grading are limited by inter-reviewer variability, require invasive biopsy procedures, and might not capture the full extent of patient risk. We sought to evaluate a deep learning (DL) model to quantify patient risk and prognosticate overall survival in kidney cancer patients via CT scans. Methods: This retrospective study used preoperative contrast CT scans from 4 public multi-institutional collections with date of death/censoring available. A deep learning (DL) network architecture was developed to analyze input CT scans via a convolutional feature extractor and a Cox proportional hazards-based cost function. The DL model assigned a risk score to each patient, with the median risk used as a cutoff for classifying patients as high-risk or low-risk. Model performance for prognosticating overall survival (OS) was evaluated separately in training, internal validation, and external validation cohorts via Kaplan-Meier analysis in terms of concordance index and hazard ratios, with risk groups compared via Wilcoxon log-rank tests (α = 0.05). Results: In the training/internal validation cohort (N=418, 8 institutions) and external validation cohort (N=102, 1 institution), the median age was 60 and 59 years, the male/female ratios were 62%/38% and 75%/25%, with a median follow up of 2.8 and 3.1 years, respectively. The DL model yielded a training c-index of 0.66 (95% CI: 0.63-0.68), internal validation c-index of 0.73 (95% CI: 0.70-0.76) and an external validation c-index of 0.67 (95% CI: 0.64-0.70). Kaplan-Meier analysis of associated survival curves based on DL-determined high- and low-risk patients demonstrated statistically significant separation in all cohorts: training (p = 0.003, HR = 8.63, 95% CI: 8.28-8.98), internal validation (p = 0.027, HR = 4.89, 95% CI: 4.52-5.26), and external validation (p = 0.01, HR = 6.54, 95% CI: 6.18-6.90). Baseline clinicopathological characteristics were not significantly different between DL high and low risk patients in external validation (chi-square testing; ISUP grade p=0.375, age p=0.824, race p=0.567, and sex p=0.440). ISUP grade was also not a significant predictor of OS in internal validation (HR=1.57, p=0.211, 95% CI: 1.28-1.85) or external validation (p = 0.465, HR=0.16, 95% CI: 0.33-0.74). Conclusion: A deep learning model based on pre-operative CT scans was found to accurately prognosticate overall survival in kidney cancers in a multi-institutional setting, independent of clinicopathological factors. This model is being validated on larger cohorts, and in the context of targeted therapies. Citation Format: Brennan Flannery, Mohsen Hariri, Thomas DeSilvio, Amir Sadri, Jane Nguyen, Erick M. Remer, Smitha Krishnamurthi, Satish E. Viswanath. Deep learning based risk stratification of pre-operative CT scans is prognostic of overall survival in kidney cancers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 7379.

Predicting postoperative prognosis in clear cell renal cell carcinoma using a multiphase CT-based deep learning model

Multicenter evaluation of CT deep radiomics model in predicting Leibovich score risk groups for non-metastatic clear cell renal cell carcinoma

A preoperative CT-based deep learning radiomics model in predicting the stage, size, grade and necrosis score and outcome in localized clear cell renal cell carcinoma: A multicenter study

Abstract 7379: Deep learning based risk stratification of pre-operative CT scans is prognostic of overall survival in kidney cancers

Deep learning-assisted survival prognosis in renal cancer: A CT scan-based personalized approach

Radiomics predicts the prognosis of patients with clear cell renal cell carcinoma by reflecting the tumor heterogeneity and microenvironment

Artificial intelligence for diagnosing and predicting survival of patients with renal cell carcinoma: Retrospective multi-center study

A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study

Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide images

A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study

Deep Learning-Based Multi-Model Prediction for Disease-Free Survival Status of Patients with Clear Cell Renal Cell Carcinoma after Surgery: a Multicenter Cohort Study.

Deep learning-based multimodel prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study

Preoperative CT Radiomics Predicting the SSIGN Risk Groups in Patients with Clear Cell Renal Cell Carcinoma: Development and Multicenter Validation

A Robust Deep Learning Method with Uncertainty Estimation for the Pathological Classification of Renal Cell Carcinoma based on CT Images

Predicting bone metastasis-free survival in non-small cell lung cancer from preoperative CT via deep learning

Preoperative prediction of renal fibrous capsule invasion in clear cell renal cell carcinoma using CT-based radiomics model

Clinical Use of a Machine Learning Histopathological Image Signature in Diagnosis and Survival Prediction of Clear Cell Renal Cell Carcinoma.

Multimodal Deep Learning for Personalized Renal Cell Carcinoma Prognosis: Integrating CT Imaging and Clinical Data

Distinguishing common renal cell carcinomas from benign renal tumors based on machine learning: comparing various CT imaging phases, slices, tumor sizes, and ROI segmentation strategies

Enhanced Computed Tomography Radiomics-Based Machine-Learning Methods for Predicting the Fuhrman Grades of Renal Clear Cell Carcinoma

Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma